Being Alive Newsletter; July 1992
Dr. Robert Schooley and reported by Walt Senterfitt
Perhaps the biggest problem is the genetic diversity of the virus. We think that neutralizing antibodies work against the envelope (outer coating) of the virus, and particularly one region of the protein which makes up this envelope. This region, however, is the most variable part of the virus (it's known as the "V3 loop"), changing considerably as different strains evolve. The danger is that neutralizing antibodies used therapeutically will be too narrow or restricted to block all the different strains present in an individual. Some researchers are working on ways around this, such as a "cocktail" of different antibodies or cloned antibodies directed at a different part of the envelope, but there are clearly going to be major problems.
920701
BA920708
Copyright © 1992 - Beings Alive. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. Being Alive, 621 N. San Vicente Blvd., West Hollywood, CA 90069, Tel - 310.289.2551; FAX - 310.289.9866; Email: BeiAlive@aol.com http://www.beingalivela.org/